Yes I agree completely - to my mind the potential value here is for PPS to become a mass-market default treatment for OA, and possibly a range of other indications. For this to happen I think the strategy would probably be to get it out there to as many people as possible, as soon as possible, and not be too ambitious on the pricing.
On the road to growth!, page-17
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $79.93K | 274.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12951 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 23984 | 3 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |